- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02278848
Multimodal Investigation in the Diagnosis and Treatment of Chronic Adult Hydrocephalus (Multimod'HCA)
Idiopathic chronic adult hydrocephalus (ICAH) is due to expansion of the fluid-filled cavities in the brain. The clinical symptoms are gait disturbance, mental decline and incontinence. Treatment involves installing a ventriculoperitoneal shunt which is known to be able to induce regression of the symptoms in many cases meaning that ICAH is a classic, curable cause of dementia. Diagnosis relies on comparing symptoms before and after depleting cerebrospinal fluid (CSF) via a lumbar puncture (LP). In practice, the situation is complicated: improvement is often incomplete and there is no consensus on either how to assess the symptoms or how they change after CSF depletion. In consequence, the decision whether not to undertake surgery often depends on the neurosurgeon's clinical impression.
Over recent years, the cognitive profile of patients with ICAH has become better characterised and reproducible, objective techniques have been developed to assess motor function and CSF flow in the brain.
The investigators project aims to define the value of these new investigative techniques in the positive diagnosis of ICAH, in comparison to current decision-making tools.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karl MONDON
- Phone Number: +33234378952
- Email: karl.mondon@med.univ-tours.fr
Study Contact Backup
- Name: Emilie BEAUFILS
- Phone Number: +33247479787
- Email: E.BEAUFILS@chu-tours.fr
Study Locations
-
-
-
Tours, France, 37044
- CHRU de Tours
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult 65 years or older
- Hospitalized patients (at the University Hospital of Tours) requiring the assessment of chronic hydrocephalus in adults, suspected clinically
- Patient undergoing Lumbar Puncture subtractive
- Informed consent form signed
- Affiliated to a medical insurance
Exclusion Criteria:
- Contraindications to MRI
- Inability to walk or to stand before having lumbar puncture
- Patient under trusteeship and guardianship, or judicial protection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Diagnosis of ICAH
One arm: patients with chronic adult hydrocephalus. All patients have: Computerised gait analysis, Ultrasound measurement of cerebral pulsatility, MRI flow, Urinary incontinence scale |
Diagnosis of ICAH using new investigative techniques (computerised gait analysis, ultrasound, MRI flow, urinary incontinence scale)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cerebrospinal fluid biomarkers of degeneration from Alzheimer's disease.
Time Frame: 5 days
|
Association between the decision-making with regard to permanent CSF shunt and the response to subtractive lumbar puncture
|
5 days
|
Computerised gait analysis
Time Frame: 5 days
|
Association between the decision-making with regard to permanent CSF shunt and the Computerised gait analysis,
|
5 days
|
Ultrasound measurement of cerebral pulsatility
Time Frame: 5 days
|
Association between the decision-making with regard to permanent CSF shunt and the Ultrasound measurement of cerebral pulsatility,
|
5 days
|
Qualitative and quantitative analysis (average speed and flow) of the hydrodynamic characteristics of the cerebrospinal fluid.
Time Frame: 5 days
|
Association between the decision-making with regard to permanent CSF shunt and the MRI flow,
|
5 days
|
Urinary incontinence
Time Frame: 5 days
|
Association between the decision-making with regard to permanent CSF shunt and the Urinary incontinence scale
|
5 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karl MONDON, CHRU de Tours
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHAO 2013- KM / Multimod'HCA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Adult Hydrocephalus
-
University Hospital, Clermont-FerrandEchodia SASUnknown
-
University of Kansas Medical CenterNot yet recruitingLow Pressure Hydrocephalus
-
Umeå UniversityCompletedIdiopathic Normal Pressure Hydrocephalus
-
Uppsala University HospitalUppsala University; Swedish Society for Medical ResearchRecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)Sweden
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences CorporationCompletedIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
-
Military University Hospital, PragueRecruitingNormal Pressure HydrocephalusCzechia
-
University Hospital, ToulouseCompleted
-
Rabin Medical CenterUnknown
-
Mayo ClinicTerminatedNormal Pressure Hydrocephalus PatientsUnited States
-
Umeå UniversityCompleted